2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 5.956

Change

+0.02 (+0.40)%

Market Cap

USD 0.49B

Volume

0.22M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.37% 42% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.37% 42% F 45% F
Trailing 12 Months  
Capital Gain 10.67% 50% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.67% 50% F 53% F
Trailing 5 Years  
Capital Gain 33.95% 53% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.95% 52% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 6.74% 67% D+ 64% D
Dividend Return 6.74% 65% D 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.73% 41% F 52% F
Risk Adjusted Return 45.78% 62% D 64% D
Market Capitalization 0.49B 68% D+ 60% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.